NO975938L - Anti-fedme proteiner - Google Patents

Anti-fedme proteiner

Info

Publication number: NO975938L
Authority: NO; Norway
Prior art keywords: obesity; obesity proteins; proteins; disability; diabetes
Prior art date: 1996-12-20

Application number

NO975938A

Other languages

English (en)

Norwegian (no)

Other versions

NO975938D0 (no

Inventor

John Michael Beals

Ronald Eugene Chance

James Arthur Hoffmann

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-20

Filing date

1997-12-17

Publication date

1998-06-22

1997-12-17 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1997-12-17 Publication of NO975938D0 publication Critical patent/NO975938D0/no

1998-06-22 Publication of NO975938L publication Critical patent/NO975938L/no

Links

230000003579 anti-obesity Effects 0.000 title abstract 2
102000004169 proteins and genes Human genes 0.000 title abstract 2
108090000623 proteins and genes Proteins 0.000 title abstract 2
208000024172 Cardiovascular disease Diseases 0.000 abstract 1
208000008589 Obesity Diseases 0.000 abstract 1
210000000577 adipose tissue Anatomy 0.000 abstract 1
201000011529 cardiovascular cancer Diseases 0.000 abstract 1
235000020824 obesity Nutrition 0.000 abstract 1
208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
General Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Child & Adolescent Psychology (AREA)
Plant Pathology (AREA)
Obesity (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Diabetes (AREA)
Toxicology (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO975938A 1996-12-20 1997-12-17 Anti-fedme proteiner NO975938L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US3356196P	1996-12-20	1996-12-20

Publications (2)

Publication Number	Publication Date
NO975938D0 NO975938D0 (no)	1997-12-17
NO975938L true NO975938L (no)	1998-06-22

Family

ID=21871119

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO975938A NO975938L (no)	1996-12-20	1997-12-17	Anti-fedme proteiner

Country Status (23)

Country	Link
EP (1)	EP0849276A1 (id)
JP (1)	JPH10179158A (id)
KR (1)	KR19980064258A (id)
CN (1)	CN1194986A (id)
AR (1)	AR013886A1 (id)
AU (2)	AU4843297A (id)
BR (1)	BR9706358A (id)
CA (1)	CA2217698A1 (id)
CO (1)	CO4700343A1 (id)
CZ (1)	CZ407097A3 (id)
HU (1)	HUP9702500A3 (id)
ID (1)	ID19257A (id)
IL (1)	IL122569A0 (id)
NO (1)	NO975938L (id)
NZ (1)	NZ329413A (id)
PE (1)	PE47599A1 (id)
PL (1)	PL323956A1 (id)
SG (1)	SG65040A1 (id)
SV (1)	SV1997000107A (id)
TR (1)	TR199701666A3 (id)
WO (1)	WO1998028335A1 (id)
YU (1)	YU48997A (id)
ZA (1)	ZA9710877B (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2338235B (en)	1997-04-15	2001-11-14	Csir	Appetite suppressing plant extracts
WO1999044598A2 (en) *	1998-03-03	1999-09-10	Board Of Regents, The University Of Texas System	Methods for inhibiting βcell apoptosis
GB9924484D0 (en) *	1999-10-15	1999-12-15	Isis Innovation	Altered polypeptide aggregation
GB2396815B (en)	1999-10-27	2004-09-08	Phytopharm Plc	A composition comprising a pregnenone derivative and an NSAID
US7022674B2 (en)	1999-12-16	2006-04-04	Eli Lilly And Company	Polypeptide compositions with improved stability
GB2363985B (en)	2000-06-30	2004-09-29	Phytopharm Plc	Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
US7985734B2 (en)	2006-06-01	2011-07-26	Yun Cheng	Peptides for preventing or treating liver damage
US12466883B1 (en) *	2024-05-13	2025-11-11	Lumen Bioscience, Inc.	Leptin compositions and methods of making and using the same to support weight loss and/or maintenance

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6309853B1 (en) *	1994-08-17	2001-10-30	The Rockfeller University	Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US5827734A (en) *	1995-01-20	1998-10-27	University Of Washington	Materials and methods for determining ob protein in a biological sample
JPH10513450A (ja) *	1995-01-31	1998-12-22	イーライ・リリー・アンド・カンパニー	抗肥満症タンパク質
WO1996024670A1 (en) *	1995-02-06	1996-08-15	Eli Lilly And Company	Human obesity gene
WO1996031526A1 (en) *	1995-04-06	1996-10-10	Amylin Pharmaceuticals, Inc.	Anti-obesity agents
GB9509164D0 (en) *	1995-05-05	1995-06-28	Smithkline Beecham Plc	Novel compounds
CA2224867A1 (en) *	1995-06-22	1997-01-09	Eli Lilly And Company	Obesity protein intermediates and their preparation and use

1997
- 1997-12-02 CA CA002217698A patent/CA2217698A1/en not_active Abandoned
- 1997-12-03 ZA ZA9710877A patent/ZA9710877B/xx unknown
- 1997-12-11 IL IL12256997A patent/IL122569A0/xx unknown
- 1997-12-16 CO CO97073281A patent/CO4700343A1/es unknown
- 1997-12-16 NZ NZ329413A patent/NZ329413A/en unknown
- 1997-12-16 EP EP97310190A patent/EP0849276A1/en not_active Withdrawn
- 1997-12-16 PE PE1997001122A patent/PE47599A1/es not_active Application Discontinuation
- 1997-12-16 SV SV1997000107A patent/SV1997000107A/es unknown
- 1997-12-16 BR BR9706358A patent/BR9706358A/pt not_active Application Discontinuation
- 1997-12-17 NO NO975938A patent/NO975938L/no not_active Application Discontinuation
- 1997-12-17 AR ARP970105941A patent/AR013886A1/es unknown
- 1997-12-17 AU AU48432/97A patent/AU4843297A/en not_active Abandoned
- 1997-12-17 KR KR1019970069938A patent/KR19980064258A/ko not_active Withdrawn
- 1997-12-17 CZ CZ974070A patent/CZ407097A3/cs unknown
- 1997-12-18 PL PL97323956A patent/PL323956A1/xx unknown
- 1997-12-18 SG SG1997004559A patent/SG65040A1/en unknown
- 1997-12-18 AU AU53846/98A patent/AU5384698A/en not_active Abandoned
- 1997-12-18 JP JP9349102A patent/JPH10179158A/ja not_active Withdrawn
- 1997-12-18 WO PCT/US1997/023344 patent/WO1998028335A1/en not_active Ceased
- 1997-12-18 CN CN97129705A patent/CN1194986A/zh active Pending
- 1997-12-18 ID IDP973915A patent/ID19257A/id unknown
- 1997-12-18 YU YU48997A patent/YU48997A/sh unknown
- 1997-12-18 HU HU9702500A patent/HUP9702500A3/hu unknown
- 1997-12-19 TR TR97/01666A patent/TR199701666A3/tr unknown

Also Published As

Publication number	Publication date
NZ329413A (en)	1999-10-28
HU9702500D0 (en)	1998-03-02
JPH10179158A (ja)	1998-07-07
ID19257A (id)	1998-06-28
CA2217698A1 (en)	1998-06-20
CN1194986A (zh)	1998-10-07
WO1998028335A1 (en)	1998-07-02
AU5384698A (en)	1998-07-17
NO975938D0 (no)	1997-12-17
TR199701666A2 (xx)	1999-10-21
CO4700343A1 (es)	1998-12-29
IL122569A0 (en)	1998-06-15
TR199701666A3 (tr)	1999-10-21
ZA9710877B (en)	1999-06-03
PL323956A1 (en)	1998-06-22
BR9706358A (pt)	1999-05-04
SG65040A1 (en)	1999-05-25
PE47599A1 (es)	1999-05-14
AR013886A1 (es)	2001-01-31
SV1997000107A (es)	1999-01-18
HUP9702500A2 (hu)	1998-07-28
HUP9702500A3 (en)	1999-07-28
AU4843297A (en)	1998-06-25
YU48997A (sh)	1999-09-27
CZ407097A3 (cs)	1998-07-15
EP0849276A1 (en)	1998-06-24
KR19980064258A (ko)	1998-10-07

Similar Documents

Publication	Publication Date	Title
DK0998287T3 (da)	2003-09-01	Anvendelse af levobupivacain
MXPA02006679A (es)	2005-12-19	Composicion farmaceutica.
AR052921A1 (es)	2007-04-11	Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
DK0944396T3 (da)	2003-06-23	Præparater og fremgangsmåder til forøgelse af tarmfunktion
BR0015974A (pt)	2002-07-23	Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto
EA200000747A1 (ru)	2000-12-25	СПОСОБ ВВЕДЕНИЯ AspB28-ИНСУЛИНА ЧЕЛОВЕКА
DK1071439T3 (da)	2006-10-16	Hybenformuleringer som antiinflammatorisk naturmedicin til lindring/reduktion af symptomer associeret med inflammation og artritis
HUP9802556A1 (hu)	1999-03-29	Eljárás és készítmény kötőszöveti kapcsolódások gyógyítására és helyreállítására
DE59811158D1 (de)	2004-05-13	Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
NO975938L (no)	1998-06-22	Anti-fedme proteiner
WO2003062273A3 (en)	2003-08-28	Modulator of the notch signalling pathway and use thereof in medical treatment
BR0111506A (pt)	2003-06-24	Complexos de droga macromoleculares e composições contendo os mesmos
TR199902980T2 (xx)	2000-05-22	Diabetin tedavisi i�in leptin antagonistlerinin kullan�m�.
DE60113304D1 (de)	2005-10-13	Verwendung von langem pentraxin ptx3 zur herstellung eines arzneimittels zur verhütung und heilung von autoimmunkrankheiten
PT1408977E (pt)	2005-08-31	Terapia de combinacao para o tratamento de falha cardiaca
BR0108261A (pt)	2003-03-05	Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono
IT1317930B1 (it)	2003-07-15	Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione
NO973515L (no)	1997-09-29	Anti-fedme proteiner
BR9713514A (pt)	2000-02-29	Novo uso de creatina
CO4820397A1 (es)	1999-07-28	TRATAMIENTO CONTRA EL ASMA CON TNFR -Ig
BR9808866A (pt)	2000-08-01	Moléculas retinóicas relacionadas à inibição da superprodução de endotelina-1 em doenças
MX9705832A (es)	1997-11-29	Proteinas contra la obesidad.
ES2189213T3 (es)	2003-07-01	Utilizacion de un compuesto de tipo retinoide para aumentar in vivo la actividad de desacoplamiento de la proteina ucp2.
Ojewole	2003	P-2: Hypotensive effect of Leonotis leonurus aqueous leaf extract in rats
BR0210902A (pt)	2004-06-08	Método de modulação da atividade de canais de cálcio em células cardìacas e reagentes para isso

Legal Events

Date	Code	Title	Description
2002-09-09	FC2A	Withdrawal, rejection or dismissal of laid open patent application